These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2546503

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Phase II study of KRN8602 (MX2) for malignant lymphoma].
    Okabe K, Sampi K, Kuraishi Y, Takemoto Y, Tamura K, Ogawa M.
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1001-6. PubMed ID: 9644314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jun; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 5. MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in refractory metastatic breast cancer: results of a preliminary phase II trial.
    Watanabe T, Narabayashi M, Haga S, Yamada Y, Kawamura E, Enomoto K, Kusama M, Kimura K, Adachi I, Abe O.
    Jpn J Clin Oncol; 1993 Aug; 23(4):246-9. PubMed ID: 8411738
    [Abstract] [Full Text] [Related]

  • 6. [Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
    Takemoto Y, Sampi K, Kuraishi Y, Toki H, Tamura K, Ogawa M.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2243-8. PubMed ID: 9881081
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
    Wakui A, Yokoyama M, Konno K, Nakai Y, Sakano T, Koyama Y, Imamura Y, Nakajima O, Niijima T, Akaza H.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
    [Abstract] [Full Text] [Related]

  • 11. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
    Akutsu M, Kano Y, Ogawa M, Miura A, Hirano M, Masaoka T, Tatsumi N.
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
    [Abstract] [Full Text] [Related]

  • 12. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
    Meguro S, Nagata T, Yokoyama K, Chinen T, Kobayashi T, Yamazaki H, Kuraishi Y, Ichiba, Abe M, Isogai Y.
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic re-evaluation and phase I study of high dose epirubicin in advanced non-small cell lung cancer.
    Nishio M, Ohata M, Kobayashi H, Suruda T, Uetani K, Funasako M, Nishio K, Sasaki Y, Saijo N.
    Jpn J Clin Oncol; 1993 Oct; 23(5):284-90. PubMed ID: 8230753
    [Abstract] [Full Text] [Related]

  • 14. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T, Niitani H, Furue H, Tsukagoshi S, Kanamaru R, Hasegawa K, Akazawa S, Yoneda S, Tominaga T, Sasaki T.
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
    [Abstract] [Full Text] [Related]

  • 15. [A phase I trial of idarubicin by oral administration].
    Ogawa M, Kimura K, Taguchi T, Wakui A, Hattori M, Shimoyama T, Fujita H.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1896-900. PubMed ID: 3473981
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].
    Masaoka T, Ogawa M, Inoue K, Sanpi K, Kuraishi Y, Toki H, Tamura K, Takagi T, Shibata A, Hirano M, Ezaki K, Shirakawa S, Matsuda T, Kimura I.
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1857-65. PubMed ID: 11729478
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.